In today’s world, when someone asks you what kind of business would you like to start, the first though in your mind is an app or a software. However, the co-founders Siddhartha Pidhadia and Sai Prashant Boyreddy were out-of-the-box thinkers and had something else in mind. They were inspired by the famous ALS Ice Bucket challenge of 2015, which went viral for a noble cause to raise money to research on cure for the disease ALS. Great Lakes Neuroscience was formed to research a cure for ALS, MS and other associated diseases.

Amyotrophic Lateral Sclerosis (ALS) a.k.a. Lou Gehrig’s disease, is a slow death. Because of the damage of nerve cells, it slowly shuts down different parts of the body starting from paralysis to difficulty in respiration. The only known survivor is the famous Stephen Hawking.

Similar to ALS, Multiple Sclerosis (MS) is also a disease caused by the damage of nerve cells. It results in paralysis of multiple parts in the body at the same time. It is said that a given life expectancy for this disease is 5 – 10 years.

Since there is no permanent cure or any FDA-approved treatment for these diseases, Great Lakes Neuroscience is preparing a drug, TP5, which they believe would be out in the market in 2 years and would be a stronger solution to MS and ALS than what presently exists. With their patented technology, it is assumed that they would be the major players in the research for this area.

The company is an attractive one for many reasons.

On a social stand point, they fulfill a century old problem and creates a possibility to cure many patients suffering and waiting for getting pulled out of the cord.

On a business standpoint, the drug would be sold on an international level, thus, a larger market to be capped.

On an investor stand point, pharmaceutical companies with quick time-to-market yield best returns on investment.

I highly anticipate the growth of this company and curious about what future projects they undertake after the success of TP5.

Website: www.greatlakesneuroscience.com

Twitter: @GLNeuro

LinkedIn: Great Lakes Neuroscience